HuMax-TF-ADC, CARBOPLATIN , PEMBROLIZUMAB , BEVACIZUMAB
GCT1015-05
Phase 2 small_molecule active
Quick answer
HuMax-TF-ADC, CARBOPLATIN , PEMBROLIZUMAB , BEVACIZUMAB for Recurrent or stage IVB cervical cancer is a Phase 2 program (small_molecule) at Genmab A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Genmab A/S
- Indication
- Recurrent or stage IVB cervical cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active